Particle News: Latest Novavax news

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

The biotech company plans to focus on licensing its technology and expanding its vaccine pipeline after declining sales of its COVID-19 vaccine.

FDA Approves Moderna’s mNEXSPIKE for High-Risk Populations

Stratus Variant Drives California COVID Wave as FDA Limits New Vaccine to High-Risk Patients

FDA Approves LP.8.1 COVID Boosters, Limits Routine Use to Seniors and High-Risk Patients

Colorado and Pennsylvania Move to Keep COVID Vaccines Available as CVS and Walgreens Curb Access

HHS Layoffs Begin as RFK Jr. Restructures Federal Health Agencies

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine